Neuroimaging on methamphetamine users with psychiatric symptoms

被引:0
|
作者
Iyo, M [1 ]
Sekine, Y [1 ]
Mori, N [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Chiba 2608670, Japan
来源
CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE | 2002年 / 53卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A long-term abuse of methamphetamine causes psychiatric symptoms, such as psychosis and anxiety disorder-like symptoms. Some of the symptoms are persistent for long time of period even after cessation of the methamphetamine use. We employed positron emission tomography (PET) studies to clarify the changes in the brain dopaminergic systems of methamphetamine abusers and the relations of the changes to their psychiatric symptoms. It was indicated that persistent reduction of dopamine transporter density in the caudate/putamen, nucleus accumbens and prefrontal cortex in the abusers, whereas the density of dopamine D2 receptors were not different from the control subjects. The results also suggested the reduction of dopamine transporter density may be closely associated with duration of methamphetamine use and severity of persistent psychiatric symptoms in methamphetamine users.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 50 条
  • [31] Mother-son relationship as a risk factor for depressive symptoms among methamphetamine users
    Semple, Shirley J.
    Strathdee, Steffanie A.
    Zians, Jim
    Patterson, Thomas L.
    JOURNAL OF SUBSTANCE USE, 2012, 17 (01) : 51 - 60
  • [32] Assessment of early psychiatric symptoms among substance users: a preliminary study
    Martorelli, C.
    Roggi, M.
    Di Volo, S.
    Bolognesi, S.
    Goracci, A.
    Fagiolini, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S693 - S694
  • [33] Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study
    Hides, Leanne
    Chan, Gary
    Dawe, Sharon
    McKetin, Rebecca
    Kavanagh, David J.
    Young, Ross McD
    Teesson, Maree
    Saunders, John B.
    BRITISH JOURNAL OF PSYCHIATRY, 2021, 219 (01) : 361 - 367
  • [34] Neuroimaging in Psychiatric Disorders
    Masdeu, Joseph C.
    NEUROTHERAPEUTICS, 2011, 8 (01) : 93 - 102
  • [35] Neuroimaging in Psychiatric Disorders
    Joseph C. Masdeu
    Neurotherapeutics, 2011, 8 : 93 - 102
  • [36] Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users
    Christine C. Cloak
    Daniel Alicata
    Thomas M. Ernst
    Linda Chang
    Journal of Neuroimmune Pharmacology, 2015, 10 : 380 - 390
  • [37] Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users
    Cloak, Christine C.
    Alicata, Daniel
    Ernst, Thomas M.
    Chang, Linda
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 (02) : 380 - 390
  • [38] Psychiatric symptoms in male cannabis users not using other illicit drugs
    Troisi, A
    Pasini, A
    Saracco, M
    Spalletta, G
    ADDICTION, 1998, 93 (04) : 487 - 492
  • [39] Risk factors and an early prediction model for persistent methamphetamine-related psychiatric symptoms
    Zhang, Yang
    Sun, Yan
    Yu, Zhoulong
    Sun, Yankun
    Chang, Xiangwen
    Lu, Lin
    Chang, Suhua
    Shi, Jie
    ADDICTION BIOLOGY, 2020, 25 (01)
  • [40] Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET
    Sekine, Y
    Iyo, M
    Ouchi, Y
    Matsunaga, T
    Tsukada, H
    Okada, H
    Yoshikawa, E
    Futatsubashi, M
    Takei, N
    Mori, N
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (08): : 1206 - 1214